Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Some Like It Sweet: Dendritic Cells Add Sugar to Their T(ea).

Cell·2020

Same author

TERT promoter mutations and monoallelic activation of TERT in cancer.

Oncogenesis·2015

Same author

Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.

Oncogene·2015

Same author

Targeted cancer therapies in the twenty-first century: lessons from imatinib.

Clinical pharmacology and therapeutics·2010

Same author

Sensing and signaling DNA damage: roles of Rad17 and Rad9 complexes in the cellular response to DNA damage.

Harvey lectures·2003

Same author

The FHA domain, a phosphoamino acid binding domain involved in the DNA damage response pathway.

Cold Spring Harbor symposia on quantitative biology·2003

Search research articles

Related Experiment Video

Updated: Jul 22, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Dissecting cancer pathways and vulnerabilities with RNAi.

T F Westbrook¹, F Stegmeier, S J Elledge

¹Howard Hughes Medical Institute, Department of Genetics, Harvard Partners Center for Genetics and Genomics, Harvard Medical School, Boston, Massachusetts 02115, USA.

Cold Spring Harbor Symposia on Quantitative Biology

|July 28, 2006

Summary

Identifying novel cancer genes and drug targets is crucial. RNA interference (RNAi) in mammalian cells enables genome-scale functional studies, aiding the discovery of cancer-signaling networks and vulnerabilities.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Related Experiment Videos

Last Updated: Jul 22, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Area of Science:

Genetics
Molecular Biology
Cancer Research

Background:

Molecular-targeted cancer therapies rely on understanding cancer pathogenesis networks.
Functional annotation of human genes is incomplete, leaving many cancer-relevant genes undiscovered.
Genetic screens in invertebrates offer insights but lack tools in mammalian cells.

Purpose of the Study:

To discuss the application of RNA interference (RNAi) for cancer gene discovery.
To explore RNAi-based approaches for elucidating cancer-signaling networks.
To identify potential cancer vulnerabilities using genome-scale genetic screens.

Main Methods:

Utilizing RNA interference (RNAi) for gene expression suppression in mammalian cells.
Applying genome-scale genetic screens to identify cancer-relevant genes.
Analyzing signaling networks involved in cancer pathogenesis.

Main Results:

RNAi has revolutionized mammalian genetics, enabling large-scale functional gene decoding.
RNAi facilitates the identification of previously unknown cancer-relevant genes.
This approach aids in uncovering critical cancer vulnerabilities.

Conclusions:

RNAi-based genetic approaches are powerful tools for cancer research.
Understanding cancer networks through RNAi can lead to new therapeutic targets.
Further application of RNAi will enhance the discovery of cancer vulnerabilities.